Inventor
LITWIN VIRGINIA M
US11 patents
⚠️ This page may combine multiple inventors who share the name “LITWIN VIRGINIA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROGENICS PHARM INC
10 patentsUS6344545B1Feb 5, 2002
Method for preventing HIV-1 infection of CD4+ cells
PROGENICS PHARM INC91 citations97
US6261763B1Jul 17, 2001
Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion
PROGENICS PHARM INC38 citations96
US6107019AAug 22, 2000
Method for preventing HIV-1 infection of CD4+ cells
PROGENICS PHARM INC78 citations96
US7345153B2Mar 18, 2008
Compounds capable of inhibiting HIV-1 infection
PROGENICS PHARM INC23 citations92
US7118859B2Oct 10, 2006
Methods for inhibiting HIV-1 infection
PROGENICS PHARM INC30 citations92
US6972126B2Dec 6, 2005
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same
PROGENICS PHARM INC33 citations92
US7935797B2May 3, 2011
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
PROGENICS PHARM INC1 citations52
US7901685B2Mar 8, 2011
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
PROGENICS PHARM INC0 citations52
US7862994B2Jan 4, 2011
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion
PROGENICS PHARM INC0 citations52
US7858298B1Dec 28, 2010
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
PROGENICS PHARM INC1 citations52